Related references
Note: Only part of the references are listed.Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways
Lukas Kraehenbuehl et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2022)
Immune-related toxicities of checkpoint inhibitors: mechanisms and mitigation strategies
Ryan J. Sullivan et al.
NATURE REVIEWS DRUG DISCOVERY (2022)
Overcoming immune resistance by sequential prodrug nanovesicles for promoting chemoimmunotherapy of cancer
Fengqi Zhou et al.
NANO TODAY (2021)
Immunostimulant hydrogel for the inhibition of malignant glioma relapse post-resection
Jing Zhang et al.
NATURE NANOTECHNOLOGY (2021)
Inhibition of post-surgery tumour recurrence via a hydrogel releasing CAR-T cells and anti-PDL1-conjugated platelets
Quanyin Hu et al.
NATURE BIOMEDICAL ENGINEERING (2021)
Neoadjuvant checkpoint blockade for cancer immunotherapy
Suzanne L. Topalian et al.
SCIENCE (2020)
Dual pH-sensitive nanodrug blocks PD-1 immune checkpoint and uses T cells to deliver NF-κB inhibitor for antitumor immunotherapy
Zecong Xiao et al.
SCIENCE ADVANCES (2020)
Localized cocktail chemoimmunotherapy after in situ gelation to trigger robust systemic antitumor immune responses
Yu Chao et al.
SCIENCE ADVANCES (2020)
A biomaterial-based vaccine eliciting durable tumour-specific responses against acute myeloid leukaemia
Nisarg J. Shah et al.
NATURE BIOMEDICAL ENGINEERING (2020)
Cation-induced shape programming and morphing in protein-based hydrogels
Luai R. Khoury et al.
SCIENCE ADVANCES (2020)
High-capacity poly(2-oxazoline) formulation of TLR 7/8 agonist extends survival in a chemo-insensitive, metastatic model of lung adenocarcinoma
Natasha Vinod et al.
SCIENCE ADVANCES (2020)
Trispecific natural killer cell nanoengagers for targeted chemoimmunotherapy
Kin Man Au et al.
SCIENCE ADVANCES (2020)
Implantable Bioresponsive Nanoarray Enhances Postsurgical Immunotherapy by Activating Pyroptosis and Remodeling Tumor Microenvironment
Hongjuan Zhao et al.
ADVANCED FUNCTIONAL MATERIALS (2020)
Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors
Lorenzo Galluzzi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
A tumor-to-lymph procedure navigated versatile gel system for combinatorial therapy against tumor recurrence and metastasis
Lin Qin et al.
SCIENCE ADVANCES (2020)
An immune cocktail therapy to realize multiple boosting of the cancer-immunity cycle by combination of drug/gene delivery nanoparticles
Jiayan Wu et al.
SCIENCE ADVANCES (2020)
Synthetic lethal combination targeting BET uncovered intrinsic susceptibility of TNBC to ferroptosis
Nandini Verma et al.
SCIENCE ADVANCES (2020)
Tumor repolarization by an advanced liposomal drug delivery system provides a potent new approach for chemo-immunotherapy
L. Ringgaard et al.
SCIENCE ADVANCES (2020)
Development of immune checkpoint therapy for cancer
Jill M. Fritz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy
Elisabeth Perez-Ruiz et al.
NATURE (2019)
Material design for lymph node drug delivery
Alex Schudel et al.
NATURE REVIEWS MATERIALS (2019)
Macroscale biomaterials strategies for local immunomodulation
Maxence O. Dellacherie et al.
NATURE REVIEWS MATERIALS (2019)
Optimising efficacy and reducing toxicity of anticancer radioimmunotherapy
Eric Deutsch et al.
LANCET ONCOLOGY (2019)
In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment
Qian Chen et al.
NATURE NANOTECHNOLOGY (2019)
Delivery technologies for cancer immunotherapy
Rachel S. Riley et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
A Dual-Bioresponsive Drug-Delivery Depot for Combination of Epigenetic Modulation and Immune Checkpoint Blockade
Huitong Ruan et al.
ADVANCED MATERIALS (2019)
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies et al.
NATURE MEDICINE (2018)
Modeling combination therapy for breast cancer with BET and immune checkpoint inhibitors
Xiulan Lai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
In situ formed reactive oxygen species-responsive scaffold with gemcitabine and checkpoint inhibitor for combination therapy
Chao Wang et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
A cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors
Tingting Wang et al.
NATURE COMMUNICATIONS (2018)
Chemotherapy Combines Effectively with Anti-PD-L1 Treatment and Can Augment Antitumor Responses
Rafael Cubas et al.
JOURNAL OF IMMUNOLOGY (2018)
Cancer immunologists scoop medicine Nobel prize
Heidi Ledford et al.
NATURE (2018)
PD-L1 Is a Therapeutic Target of the Bromodomain Inhibitor JQ1 and, Combined with HLA Class I, a Promising Prognostic Biomarker in Neuroblastoma
Ombretta Melaiu et al.
CLINICAL CANCER RESEARCH (2017)
Prospects for combining targeted and conventional cancer therapy with immunotherapy
Philip Gotwals et al.
NATURE REVIEWS CANCER (2017)
Engineering Polymer Hydrogel Nanoparticles for Lymph Node-Targeted Delivery
Stefaan De Koker et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy
Christina Pfirschke et al.
IMMUNITY (2016)
Share Paper
